Sarcoidosis associated with interferon-α therapy for chronic hepatitis C

Journal of Hepatology

Volumn 28, Issue 6, 1998, Pages 1058-1063

  Hoffmann, Robert M ^b   Jung, Maria Christina ^c   Motz, Reinhard ^c   Gößl, Christoph ^c   Emslander, Hans Peter ^a   Zachoval, Reinhard ^c   Pape, Gerd R ^c  

^a Kreiskrankenhaus Erding   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c NONE

Author keywords

Chronic hepatitis C; Interferon ; Sarcoidosis; Th1 immune response

Indexed keywords

RECOMBINANT ALPHA2A INTERFERON; RIBAVIRIN;

ADULT; ARTICLE; CASE REPORT; CHRONIC HEPATITIS; DRUG MIXTURE; HELPER CELL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LUNG SARCOIDOSIS; MALE; PRIORITY JOURNAL; REMISSION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032102911     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80357-7     Document Type: Article

References (29)

1. Dusheiko G. Side effects of alpha interferon in chronic hepatitis C. Hepatology. 26:(Suppl 1):1997;112-121.
2. Chin K, Tabata C, Satake N, Nagai S, Moriyasu F, Kuno K. Pneumonitis associated with natural and recombinant interferon alfa therapy for chronic hepatitis C. Chest. 105:1994;939-941.
3. Yufu Y, Yamashita S, Nishimura J, Nawata H, Hirata J. Interstitial pneumonia caused by interferon-alpha in chronic myelogenous leukemia [letter]. Am J Hematol. 47:1994;253.
4. Teragawa H, Hondo T, Takahashi K, Watanabe H, Hirotoki O, Hattori N, et al. Sarcoidosis after interferon therapy for chronic active hepatitis C. Intern Med. 35:1996;19-23.
5. Abdi E, Nguyen G, Ludwig R, Dickout W. Pulmonary sarcoidosis following interferon therapy for advanced renal cell carcinoma. Cancer. 59:1987;896-900.
6. Nakajima M, Kubota Y, Miyashita N, Niki Y, Matsushima T, Manabe T. Recurrence of sarcoidosis following interferon alpha therapy for chronic hepatitis C. Intern Med. 35:1996;376.
7. Bobbio Pallavicini E, Valsecchi C, Tacconi F, Moroni M, Porta C. Sarcoidosis following beta-interferon therapy for multiple myeloma. Sarcoidosis. 12:1995;140.
8. Ohata I, Ochi T, Kurebahashi S, Masutani H, Kikui M. A case of subcutaneous sarcoid nodules induced by interferon-alpha. Nippon Kyobu Shikkan Gakkai Zasshi. 32:1994;996. (in Japanese, abstract in English).
9. Mitchell DN, Scadding JG. Sarcoidosis. Am Rev Respir Dis. 110:1994;774.
10. Hunninghake GW, Crystal RG. Pulmonary sarcoidosis. A disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med. 305:981;429-434.
11. Konishi K, Moller DR, Saltini C, Kirby M, Crystal FR. Spontaneous expression of the interleukin 2 receptor gene and presence of functional interleukin 2 receptors on T-lymphocytes in the blood of individuals with active pulmonary sarcoidosis. J Clin Invest. 82:1988;775-781.
12. Du Bois RM, Kirby M, Balbi B, Saltini C, Crystal FR. T-lymphocytes that accumulate in the lung in sarcoidosis have evidence of recent stimulation of the T-cell antigen receptor. Am Rev Respir Dis. 154:1992;1205-1211.
13. Silver RF, Crystal FR, Moler DR. Limited heterogeneity of biased T-cell receptor Vβ gene usage in lung but not blood T cells in active pulmonary sarcoidosis. Immunology. 88:1996;516-523.
14. + T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients. PNAS. 91:1994;4965-4969.
15. Mossman TR, Coffman RL. Th1 and T2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 7:1989;145-173.
16. Gajewski TF, Schell SR, Nau G, Fitch FW. Regulation of T-cell activation: differences among T-cell subsets. Immunol Rev. 11:1989;79-110.
17. Mossman TR, Moore KW. The role of IL-10 in cross-regulation of Th1 and Th2 responses. Immunol Today. 12:1991;49-53.
18. Trinchieri G. Interleukin 12: a cytokine produced by antigen presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood. 84:1994;4408-4427.
19. Walker C, Bauer W, Braun K, Menz G, Braun F, Schwarz T, et al. Activated T-cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med. 150:1994;1038-1048.
20. Moller DR, Formann JD, Liu MC, Noble PW, Greenlee BM, Vyas P, et al. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol. 156:1996;4952-4960.
21. Lindahl P, Leary P, Gresser I. Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes. PNAS. 69:1972;721-725.
22. Lindahl P, Leary P, Gresser I. Enhancement of the expression of histocompatibility antigens of mouse lymphoid cells of interferon in vitro. Eur J Immunol. 4:1974;779-794.
23. + T cell recruitment into tisue. J Immunol. 153:1994;1264-1270.
24. Parronchi P, Mohapatra S, Sampognaro S, Giannarini L, Wahn U, Chong P, et al. Effects of interferon-α on cytokine profile, T cell receptor repertoire and peptide reactivity of human allergen-specific T cells. Eur J Immunol. 26:1996;697-703.
25. Ezernieks J, Schnarr B, Metz K, Duschl A. The human IgE germline promoter is regulated by interleukin 4, interleukin 13, interferon-alpha and interferon-gamma via an interferon-gamma activated site and its flanking regions. Eur J Biochem. 240:1996;667-673.
26. Finkelmann FD, Svetic A, Gresser I, Snapper C, Holmes J, Trotta PP. Regulation by interferon alpha of immunoglobulin isotype selection and lymphokine production in mice. J Exp Med. 174:1991;1179-1188.
27. + T cells. J Clin Invest. 97:1996;309-315.
28. Bodenheimer HC, Lindsay KL, Davis GL, Lewis JH, Thung SN, Seeff LB. Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial. Hepatology. 26:1997;473-477.
29. Ning Q, Brown D, Parodo J, Cattral M, Fung L, Liu M, et al. Ribavirin inhibits viral induced macrophage production of tumor necrosis factor, interleukin 1 and procoagulant activity and preserves Th1 cytokine production, but inhibits Th2 cytokine response [abstract]. Hepatology. 24:1996;355.